English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

BACKGROUND: The Canadian Ward Surveillance Study(CANWARD 2007) tested isolates collected from January to December2007 from 12 Canadian hospitals to a range of antimicrobial agents.The present paper focuses on antimicrobial resistance in Streptococcuspneumoniae in Canadian hospitals, with an emphasis on macrolideresistance.MEtHODS: Minimum inhibitory concentrations of antimicrobial agentswere determined using the broth microdilution method and interpretedaccording to Clinical and Laboratory Standards Institute breakpoints.Macrolide-nonsusceptible strains (clarithromycin minimum inhibitoryconcentrations 0.5 μg/mL or greater) were analyzed by multiplex polymerasechain reaction for the presence of mefA and ermB genes.RESULTS: S pneumoniae represented 9.0% (706 of 7881) of all isolatescollected in CANWARD 2007. Of the 706 S pneumoniae isolates collected,33.1% (234) were from blood and 66.9% (472) were fromrespiratory specimens. The overall resistance (resistant and intermediate)rates for S pneumoniae isolated from respiratory and blood specimens,respectively, were: penicillin (23.9%, 14.4%), clarithromycin(22.1%, 12.6%), trimethoprim-sulfamethoxazole (14.7%, 11.5%),doxycycline (7.8%, 5.1%) and clindamycin (7.1%, 3.3%). Multidrugresistance (resistance to penicillin, clarithromycin and trimethoprimsulfamethoxazole)accounted for 2% (n=9) and 0.5% (n=1) of respiratoryand blood isolates, respectively. Susceptibility of 95% or greaterwas found with amoxicillin-clavulanic acid (99.5%, 99.3%), ceftriaxone(99.5%, 100%), cefuroxime (95.0%, 96.8%), ertapenem (99.8%,100%), meropenem (96.1%, 99.5%) and levofloxacin (99.1%, 100%)for respiratory and blood specimens, respectively. No resistance tovancomycin, tigecycline, cethromycin or telithromycin was found.mefA was present in 53.6% (52 of 97) of respiratory and 59.3% (16of 27) of blood macrolide-nonsusceptible S pneumoniae, while ermBwas present in 38.1% (37 of 97) of respiratory and 37% (10 of 27) ofblood isolates. Eight of 97 (8.2%) respiratory and one of 27 (3.7%)blood isolates contained both mefA and ermB genes.CONCLUSIONS: S pneumoniae is a common organism isolated fromclinical specimens in Canadian hospitals. Resistance was highest topenicillin and clarithromycin, while ceftriaxone and levofloxacin susceptibilitywere both greater than 99%. No isolates resistant to vancomycin,tigecycline, linezolid or the ketolides were found. Resistancerates were higher among respiratory tract isolates of S pneumoniae thanamong blood isolates. Macrolide efflux, mefA, was the predominantmechanism of macrolide resistance among both respiratory and bloodclarithromycin-nonsusceptible isolates

Antimicrobial-ResistantStreptococcus pneumoniaein Canadian Hospitals: Results from the 2007 CANWARD Study